The FDA updated warnings for Pfizer and Moderna COVID-19 vaccines to includes risks of myocarditis and pericarditis. A follow-up study showed some individuals who developed myocarditis after ...

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

A June 24 Facebook post (direct link, archive link) shows an image of COVID-19 vaccine vials. “Oxford University: Myocarditis and Pericarditis Only Appear After COVID Vaccination, Not After COVID ...

No elevation of markers of myocardal lesion (i.e., troponin) No evidence of new wall motion abnormalities or ventricular dysfunction † † In case of new evidence of wall motion abnormalities or ...

New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis, have been published today at ESC Congress 2025. This is the first time the ESC has published ...

A UK study reveals COVID-19 poses greater long-term cardiac and clotting risks in children compared to minimal vaccine ...

In March 2024, the U.S. Centers for Disease Control and Prevention released an entirely redacted, 148-page study on myocarditis outcomes after a COVID-19 vaccination. In March 2024, anti-vaccine ...

About The Study: In this study, clonal hematopoiesis of indeterminate potential (CHIP) was a strong risk factor for myocarditis and pericarditis among middle-aged adults. Targeting CHIP and its ...

About The Study: In this prespecified analysis of the DANFLU-2 trial, the risk of incident myocarditis or pericarditis was lower among individuals randomized to high-dose inactivated influenza vaccine ...

The Food and Drug Administration has expanded its existing warnings for the two leading COVID-19 vaccines to highlight a rare heart-related side effect, primarily observed in young men. On June 25, ...